Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
LISCure's Phase 2 Drug Candidate Granted Orphan Drug Designation (ODD) from US FDA 2022-12-08 22:00
Waterdrop CEO Peng Shen Elected as Vice Chairman of Alumni Association of Zhejiang University-The Hong Kong Polytechnic University Joint Center 2022-12-08 21:30
CABIO Showcases the Latest Research Results and Innovative Solutions at Food Ingredients Europe 2022 2022-12-08 21:00
PharmAbcine to Participate in the 41th Annual J.P. Morgan Healthcare Conference and Biotech Showcase™ 2023 during JPM Week 2022-12-08 21:00
Japanese Healthcare Startup Ubie, Inc. Closes Extended Series C Round at $45 million, Establishes Subsidiary in NY 2022-12-08 16:00
Createrna Announces Positive Top-Line Results from Phase 1 Clinical Trials of QR052107B Tablet in Healthy Volunteers 2022-12-08 14:29
BSR KOREA Introduces "Wizbiosolutions Inc." as "2022 Global Procurement Marketer" 2022-12-08 00:00
Newtown's Apple to Highly Saturated Global Molecular Market, TIANGEN TGuide S16 Automated Nucleic Acid Extractor Showcased at Cell Bio 2022 2022-12-06 21:04
Akeso Inc. Announces Collaboration and License Agreement for Up to US$5 Billion with Summit Therapeutics to Accelerate Global Development and Commercialization of its Breakthrough Bispecific Antibody, Ivonescimab (PD-1/VEGF) 2022-12-06 21:01
Daewoong Pharmaceutical announces success in developing a new antidiabetic medication and its aims to enter the market in over 50 countries by 2030 2022-12-06 20:00
Waterdrop Inc. Announces Third Quarter 2022 Unaudited Financial Results 2022-12-06 16:30
University of Tokyo and Sekisui House Launch Joint Research on Biodiversity and Health 2022-12-06 14:00
SK Biopharmaceuticals Wins Export Award for Cenobamate 2022-12-06 08:00
Meihua International Medical Technologies Co., Ltd. Appoints New CEO, CFO and Directors 2022-12-05 22:33
China Pharma Holdings, Inc. Announced the Acquisition of Dry Eye Disease Therapeutic Device Project 2022-12-05 21:00
Zhongchao Inc. Established SID Liver Cancer Comprehensive-Disciplinary Physician Education Platform 2022-12-05 20:30
Program CD47, provided the CMC service by GenScript ProBio to InnobationBio, will further be advanced by the joint venture between Liminatus Pharma LLC and Iris Acquisition Corp 2022-12-05 20:00
The First IBCC Unveiled in Hainan 2022-12-05 15:55
Seoul National University Bundang Hospital Presents Study of SK Biopharmaceuticals' Seizure Detection Wearable Device at AES 2022 2022-12-05 08:00
Qilu Pharmaceutical Releases Latest Results of QL1604 plus Chemotherapy as First-Line Treatment for Patients with Advanced Cervical Cancer in the Phase II Study at ESMO Asia Congress 2022 2022-12-04 17:00
1 124 125 126 127 128 812